The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation
about
Patient considerations and drug selection in the treatment of idiopathic pulmonary fibrosisPirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-AnalysisMMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosisTreatment of idiopathic pulmonary fibrosis: a network meta-analysis.Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries.Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UKCurrent best practice in rehabilitation in interstitial lung disease.Identification of Key Cost Generating Events for Idiopathic Pulmonary Fibrosis: A Systematic Review.Translation and validation of the King's Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch.Nintedanib for Idiopathic Pulmonary Fibrosis.The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.Economic consequences of idiopathic pulmonary fibrosis in Denmark.
P2860
Q26750418-F35A6940-E470-4D66-BF00-B528CAF24472Q26797272-7EAAAA8F-FEE6-4796-83E8-D58A1A9BDF7CQ33574837-71360718-2D7A-4B45-974D-7A08B63DF942Q35914125-A4A116D1-1E01-4E77-909A-D2F2D58171EBQ36239414-E6C8DD83-26E0-43C9-AF27-9B5CF0A5AA5BQ37080510-A7D30649-146A-4687-914E-FC8974799E9FQ37710138-0D9BA1E1-CF51-45EB-A006-89FF8FE296CCQ38762996-A89B20D0-282D-479C-9B4B-16856C439414Q38793193-BC50CEA4-DE7C-490D-A219-5C21CAB54E60Q47101057-E28A5A43-E0CC-410B-8E7A-BAAEBACF4D62Q47826077-DCF81D69-CFB1-4E19-92E2-AB3244B7C103Q51410723-29B87E7E-5E8E-4B5C-AAB6-A52D3D4D1720Q55311568-2463426B-BA0F-4FA6-AAE3-C154BF86A204
P2860
The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
The effectiveness and cost-eff ...... and health economic evaluation
@ast
The effectiveness and cost-eff ...... and health economic evaluation
@en
The effectiveness and cost-eff ...... and health economic evaluation
@en-gb
The effectiveness and cost-eff ...... and health economic evaluation
@nl
type
label
The effectiveness and cost-eff ...... and health economic evaluation
@ast
The effectiveness and cost-eff ...... and health economic evaluation
@en
The effectiveness and cost-eff ...... and health economic evaluation
@en-gb
The effectiveness and cost-eff ...... and health economic evaluation
@nl
prefLabel
The effectiveness and cost-eff ...... and health economic evaluation
@ast
The effectiveness and cost-eff ...... and health economic evaluation
@en
The effectiveness and cost-eff ...... and health economic evaluation
@en-gb
The effectiveness and cost-eff ...... and health economic evaluation
@nl
P2093
P2860
P31
P50
P921
P3181
P356
P1476
The effectiveness and cost-eff ...... and health economic evaluation
@en
P2093
Andy J Clegg
Athol Wells
Jeremy Jones
Katherine M A O'Reilly
Sally Singh
Vicky R Copley
P2860
P2888
P3181
P356
10.1186/2050-6511-15-63
P407
P577
2014-01-01T00:00:00Z
P5875
P6179
1020594313